This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]

Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]

Zoe Bond, Dana Li and Rebecca Wills Diabetes and Fracture Risk Diabetes mellitus, commonly known as diabetes, is a condition that affects the hormone insulin, resulting in high blood sugar […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Dr. Marla Shapiro spoke at the recent CNS Day at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO Paris 2019) on patient empowerment. Watch this short video where Dr. […]

SIGNS AND SYMPTOMS A disease that develops without any symptoms. The First Warning Sign of Osteoporosis is Frequently A Fracture Osteoporosis is a disease that takes years to develop without […]

ABOUT THE DISEASE What is Osteoporosis? Osteoporosis is a disease that slowly, quietly weakens bones, often going undiagnosed – even when it breaks them. Osteoporosis is caused by low bone […]